Mounjaro®
Starting from £179.99/mo
Start journey Learn moreIf you lift weights or train seriously and you're also considering Mounjaro for weight management, the question isn't really 'can these two things coexist' — it's 'how do I make them work together without losing what I've built?' Mounjaro (tirzepatide) is a prescription-only medicine licensed in the UK for weight management in adults, and a prescriber, not a training plan, decides whether it's clinically suitable for you. But the underlying question (what happens to muscle, performance and body composition when you combine a GLP-1 and GIP dual agonist with resistance training) is a legitimate one, and it deserves a straight answer rooted in what the evidence actually says.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
This is the thing most people in training want to know first. In the SURMOUNT-1 trial (which involved over 2,500 adults and ran for 72 weeks) participants on the highest tirzepatide dose lost around 20–21% of body weight on average, according to data published in the New England Journal of Medicine. That's a significant reduction. The important detail for anyone with a training background is that weight lost during a calorie deficit, whether drug-assisted or not, is never pure fat. Some lean mass loss is expected. The GLP-1 medicines don't uniquely attack muscle tissue, but the calorie restriction they enable does create conditions where the body may draw on lean stores if protein intake and training stimulus are insufficient.
The practical implication is straightforward: resistance training and protein adequacy are your main tools for protecting the physique you've built. That's not a novel insight for anyone who lifts, but it becomes more urgent when a medicine is suppressing appetite as effectively as tirzepatide can. Eating enough protein when you're not hungry is harder than it sounds. Planning it (much like you'd plan a training split) matters more on this treatment than off it. You can read more about the specific physiology in our piece on building muscle on Mounjaro.
Tirzepatide slows gastric emptying. For weight management, this is largely the point: food moves through more slowly, you feel full longer, and total intake drops. For someone trying to fuel training, it introduces friction at the exact moments nutrition timing matters.
Pre-workout meals may sit heavier. Post-training protein absorption can feel sluggish. Some people find high-volume protein meals uncomfortable, particularly in the early weeks or after a dose step-up. The gastrointestinal side effects that are most commonly reported (nausea, bloating, indigestion) tend to peak around dose increases and ease within a couple of weeks, as the NHS tirzepatide page confirms. The practical strategy most people land on is shifting toward smaller, more frequent protein servings rather than two large meals, and being honest with themselves about hydration, which can slip if nausea puts you off drinking.
Training intensity may genuinely dip in the first few weeks at a new dose. That's not failure; it's physiology. The body is adjusting to a different energy intake and a gut that's working differently. Scaling back volume temporarily, rather than pushing through and compounding the fatigue, is usually the more useful call. Any adjustments to treatment, timing or doses should go through your prescriber.
This is where the decision-led framing of this page becomes concrete. If you're considering Mounjaro and you train seriously, the clinical conversation isn't just about your BMI and health conditions, it should also include what you're trying to achieve. Mounjaro is licensed for adults with a BMI of 30 or above, or 27 and above if at least one weight-related condition is present. BMI alone doesn't determine suitability; a prescriber looks at the whole picture. Someone carrying significant lean mass may have a higher BMI than their body composition suggests, and that's worth raising.
The treatment's goal, clinically, is weight management alongside a reduced-calorie diet and increased physical activity. For someone already doing the 'increased physical activity' part at high volume, the conversation shifts to how to structure the combination safely. There's no rule that says competitive or recreational bodybuilders can't be treated with tirzepatide, but the prescriber needs to know your training context to give you accurate guidance. Checking the full range of effects tirzepatide has on the body before your consultation is a reasonable place to start. If you want to understand the cost side of treatment before booking, our Mounjaro pricing page sets out what's included in a private prescription. One note on timing: if you're planning ahead for a competition cut or a bulk phase, ordering before midday on a weekday means your prescription can be reviewed and dispatched the same day, arriving the next working day, worth factoring in around holidays or event schedules.
A few things are worth flagging explicitly in your consultation. First, your current training volume and structure, this shapes how aggressively a calorie deficit is appropriate and what protein targets are realistic. Second, any supplements you use regularly, particularly pre-workouts or high-dose stimulant stacks, which may interact with cardiovascular response. Third, any joint or muscle discomfort you're already managing; some people on tirzepatide notice body aches in the early weeks, and distinguishing training soreness from treatment effects is easier if you have a baseline.
Finally, if you're interested in the broader pharmacology (how tirzepatide accumulates and clears, how it differs from single-pathway GLP-1 medicines, or what the raw compound data shows) there are resources for each of those questions, including our page on tirzepatide raw material for those who want to understand what the compound itself involves. Understanding how Mounjaro builds up in the body over successive doses is particularly relevant if you're thinking about cycling treatment around competition periods; that's a conversation your prescriber can guide you through, based on your specific situation and the licensed guidance.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.